TCT-296 Prevalence of residual shunt at 6-month follow-up after percutaneous PFO closure with Amplatzer and Occlutech occluders
JACC · 2026-11 · 88 (18) · B127-B128
DOI: 10.1016/j.jacc.2026.09.389 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC, 2026-11. Verfasst von Jelle Nieuwendijk und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Nieuwendijk, J., Bouziani, A. E., Witte, L., Robbers-Visser, D., Straver, B., Delewi, R., Winter, R. D., Beijk, M., Kley, F. V. D., & Grundeken, M. (2026). TCT-296 Prevalence of residual shunt at 6-month follow-up after percutaneous PFO closure with Amplatzer and Occlutech occluders. JACC, 88(18), B127-B128. https://doi.org/10.1016/j.jacc.2026.09.389
Vancouver
Nieuwendijk J, Bouziani AE, Witte L, Robbers-Visser D, Straver B, Delewi R, et al. TCT-296 Prevalence of residual shunt at 6-month follow-up after percutaneous PFO closure with Amplatzer and Occlutech occluders. JACC. 2026;88(18):B127-B128. doi:10.1016/j.jacc.2026.09.389
BibTeX
@article{Nieuwendijk2026,
author = {Nieuwendijk, Jelle and Bouziani, Abdelhak el and Witte, Lars and Robbers-Visser, Danielle and Straver, Bart and Delewi, Ronak and Winter, Robbert de and Beijk, Marcel and Kley, Frank van der and Grundeken, Maik},
title = {TCT-296 Prevalence of residual shunt at 6-month follow-up after percutaneous PFO closure with Amplatzer and Occlutech occluders},
journal = {JACC},
year = {2026},
volume = {88},
number = {18},
pages = {B127--B128},
doi = {10.1016/j.jacc.2026.09.389}
}
EUVIMED